By Fisher, JD, CHC, CCEP
Client Alert: OIG Advisory Opinions on Gainsharing Arrangements Since 2018
Introduction to Gainsharing Arrangements
As hospitals, health systems, and physician groups continue to pursue value-based care strategies, gainsharing arrangements remain an important—but highly regulated—tool for aligning clinical and financial incentives. Properly structured, these arrangements can encourage standardization, reduce unnecessary costs, and support quality improvement. However, because gainsharing arrangements often involve payments from hospitals or health systems to physicians based on cost savings, the arrangements must be evaluated carefully under federal fraud-and-abuse laws, including the Civil Monetary Penalties Law, the Anti-Kickback Statute, and, where applicable, the Stark Law.
Recent OIG advisory opinions and related guidance underscore that the permissibility of gainsharing depends less on the existence of savings and more on the safeguards surrounding the methodology, payment structure, quality controls, and protection of independent clinical judgment. This client alert summarizes the legal framework governing gainsharing arrangements, highlights key OIG guidance and related authorities, and identifies practical compliance considerations for providers seeking to design or update gainsharing programs.
Overview of Gainsharing Arrangements
Gainsharing arrangements are collaborative financial structures through which hospitals, health systems, and physicians seek to align economic incentives around clinically appropriate cost efficiencies. In a typical arrangement, participating providers may receive a portion of documented savings generated by defined initiatives, provided those savings are achieved without reducing medically necessary care or compromising quality. Properly structured, gainsharing can support value-based care objectives; improperly structured, it may present significant fraud-and-abuse risk.
These arrangements can take several forms depending on the clinical setting, the participating providers, and the types of efficiencies being targeted.
Common Gainsharing Models
Common gainsharing models include arrangements between hospitals and surgical groups to standardize medical supplies, implement evidence-based protocols, improve operating-room utilization, or optimize staffing and scheduling. Similar models may involve anesthesiology groups focused on pharmaceutical utilization or perioperative workflow improvements. In each case, the compliance analysis turns on whether the savings methodology is objective, clinically grounded, and insulated from incentives to reduce or withhold medically necessary services.
Beyond these common hospital-based examples, gainsharing principles can also apply across other specialties where standardized practices may reduce unnecessary costs.
Additional Specialty Examples of Gainsharing Arrangements
Gainsharing principles may also apply in specialty contexts such as cardiology, where physicians may collaborate on implantable device standardization or procedural protocols, and in primary care, where practices may seek to reduce unnecessary laboratory testing or imaging. Across settings, the key determinants of defensibility are transparency, objective measurement, patient-protection safeguards, and ongoing oversight.
Because these models implicate fraud and abuse considerations, OIG guidance remains central to evaluating whether a proposed arrangement is appropriately structured.
Recent Developments in OIG Guidance
The Office of Inspector General of the U.S. Department of Health and Human Services (“OIG”) has continued to shape the compliance framework for gainsharing through advisory opinions and related fraud-and-abuse guidance. Advisory Opinion 17-09, issued January 5, 2018, remains a significant post-MACRA reference point because it addresses a neurosurgery group’s proposed participation in savings generated by defined surgical cost-reduction measures.
The OIG’s post-2018 guidance underscores a consistent theme: gainsharing arrangements may be permissible where they are carefully circumscribed, supported by objective data, subject to meaningful quality controls, and designed to avoid incentives to stint on care or generate referrals. Conversely, arrangements that simply reward lower utilization or reduced spending, without robust clinical and compliance safeguards, remain vulnerable to regulatory challenge.
Healthcare organizations evaluating gainsharing initiatives should therefore approach these arrangements as regulated compensation structures, not merely operational cost-savings programs. Legal, compliance, finance, clinical, and quality stakeholders should be engaged early, and the arrangement should be documented with sufficient rigor to withstand retrospective review by regulators, auditors, or enforcement authorities.
Key Laws and Regulations Implicated
The threshold legal question in any gainsharing analysis is whether payments to physicians could be characterized as improper remuneration, an inducement to reduce or limit care, or a reward for referrals. The Civil Monetary Penalties Law provision addressing hospital payments to physicians to reduce or limit services to Medicare or Medicaid beneficiaries is central to this analysis. Although MACRA narrowed the gainsharing prohibition by focusing it on reductions or limitations of medically necessary services, the provision remains a core statutory constraint on savings-based physician compensation.
The federal Anti-Kickback Statute is also implicated because shared-savings payments may constitute remuneration if one purpose of the payment is to induce or reward referrals of federal healthcare program business. Depending on the structure of the parties’ financial relationships, the federal physician self-referral law, commonly known as the Stark Law, may also require analysis where a physician refers designated health services payable by Medicare to an entity with which the physician has a financial relationship. OIG advisory opinions serve as important interpretive guideposts, but they do not eliminate the need for arrangement-specific legal review.
Accordingly, a defensible gainsharing structure should expressly address the Civil Monetary Penalties Law, the Anti-Kickback Statute, any applicable Stark Law analysis, and the specific OIG guidance relevant to the proposed arrangement. The agreement should document how the program preserves medically necessary care, separates shared savings from referral volume or value, relies on objective and verifiable metrics, and incorporates meaningful quality, utilization, and patient-safety monitoring.
One of the most important recent guideposts is Advisory Opinion 17-09, which illustrates how the OIG analyzes specific gainsharing safeguards in practice.
Advisory Opinion 17-09: Key Compliance Safeguards
In Advisory Opinion 17-09, the OIG evaluated a proposed arrangement under which a neurosurgery group would share in savings generated by specified measures to reduce surgical costs. The OIG’s favorable analysis turned on a series of safeguards, including objective and transparent savings criteria, assurances that medically necessary care would not be reduced or withheld, robust monitoring of patient outcomes, and clear documentation and periodic review. The opinion remains instructive because it demonstrates how the OIG assesses whether a gainsharing arrangement is designed to promote efficiency without compromising clinical judgment or patient care.
That opinion also provides a useful framework for understanding the themes that have continued to appear in later OIG guidance.
Post-2018 Advisory Opinion Themes
Subsequent OIG guidance has continued to emphasize the same foundational principles: objective metrics, transparent methodology, quality safeguards, and protection against inappropriate reductions in care. The practical lesson for providers is that gainsharing arrangements are likely to receive more favorable scrutiny when they are narrowly tailored, clinically validated, prospectively documented, and subject to ongoing compliance and quality oversight.
Taken together, these opinions point to several practical steps providers should consider when designing, reviewing, or updating gainsharing arrangements.
Representative Legal Authorities and Case Examples
Gainsharing doctrine has evolved principally through OIG advisory opinions, enforcement guidance, and statutory amendments, rather than through an extensive body of reported court decisions addressing gainsharing directly. Nevertheless, several authorities are particularly instructive when designing or evaluating these arrangements.
OIG Special Advisory Bulletin on Gainsharing Arrangements. In 1999, the OIG expressed concern that many hospital-physician gainsharing arrangements could violate the Civil Monetary Penalties Law where payments tied to reduced costs could be construed as inducements to reduce or limit services furnished to Medicare or Medicaid beneficiaries. The bulletin remains an important historical marker in the development of gainsharing compliance analysis.
OIG Advisory Opinions 05-01 through 05-06. In 2005, the OIG issued a series of favorable advisory opinions involving hospital-physician gainsharing proposals with cardiac surgeons and cardiologists. The opinions are significant because the OIG’s conclusions depended on detailed safeguards, including objective cost-savings measures, individualized patient-care decision-making, preservation of medically appropriate product choice, and monitoring designed to prevent stinting, cherry-picking, or referral-based incentives.
OIG Advisory Opinion 17-09. This post-MACRA opinion involved a medical center and neurosurgeons sharing savings from spinal-surgery cost-reduction measures. The OIG declined to impose sanctions based on safeguards that included per-capita distribution, limits on individual physician incentives, patient notice, quality monitoring, certifications that medically necessary services would not be reduced, and documentation of the cost-saving methodology.
Anti-Kickback Statute case law as an analog. Although reported decisions specific to gainsharing are limited, Anti-Kickback Statute case law remains highly relevant. Decisions such as United States v. Greber and United States v. Kats are commonly cited for the proposition that remuneration may violate the statute if even one purpose of the payment is to induce referrals, notwithstanding the existence of other legitimate business purposes.
Taken together, these authorities make clear that the legal analysis is not satisfied by demonstrating cost savings alone. The more important inquiry is whether the methodology and payment structure avoid incentives to reduce medically necessary care, steer referrals, select lower-risk patients, or compromise independent clinical judgment.
Impact on Providers
For hospitals, health systems, and physician groups, the implications of OIG gainsharing guidance are substantial. Gainsharing remains a potentially useful tool for advancing value-based care, reducing unnecessary costs, and promoting clinical standardization. However, providers must be prepared to demonstrate that any shared savings are attributable to appropriate efficiencies rather than reduced access, diminished quality, or referral generation.
Operationally, providers should expect to make meaningful investments in data analytics, quality monitoring, governance, and internal review before payments are made. Effective implementation typically requires coordination among clinical leadership, finance, compliance, legal, quality, and operations stakeholders to define cost-saving measures, validate clinical appropriateness, and monitor patient outcomes.
From a financial perspective, gainsharing can align hospital and physician incentives around efficiency, but the compensation opportunity is constrained by fraud-and-abuse considerations. Payments should be capped, calculated pursuant to objective methodologies, and demonstrably independent of the volume or value of referrals. Poorly structured arrangements may create exposure under the Civil Monetary Penalties Law, the Anti-Kickback Statute, and, where applicable, the Stark Law.
Clinically, the OIG’s guidance places patient safety and quality of care at the center of the analysis. Providers should be able to demonstrate that the arrangement does not encourage physicians to stint on care, avoid higher-risk patients, use inappropriate products, or forgo medically necessary services. Strong gainsharing programs therefore pair cost-saving targets with quality benchmarks, patient notice where appropriate, periodic audits, and mechanisms to suspend or revise the program if adverse trends emerge.
In practical terms, providers should treat gainsharing as a regulated compliance initiative requiring disciplined governance, not as a standalone incentive program. The more directly an arrangement affects physician behavior, product selection, service utilization, or referral patterns, the more important it becomes to build in objective metrics, written safeguards, independent review, and contemporaneous documentation.
Practical Takeaways for Providers
Providers considering gainsharing arrangements should consider the following governance and compliance principles:
• Identify the governing legal framework at the outset, including the Civil Monetary Penalties Law, the Anti-Kickback Statute, any applicable Stark Law considerations, MACRA’s impact on the gainsharing CMP, and relevant OIG advisory opinions.
• Ensure all gainsharing arrangements are based on transparent, objective criteria for cost savings.
• Implement safeguards to prevent reductions in medically necessary services and maintain high standards of patient care.
• Establish robust monitoring and auditing processes to track outcomes and compliance.
• Document the arrangement thoroughly, including the rationale, metrics used, and compliance protocols.
• Regularly review and update the arrangement in light of new OIG guidance and regulatory changes.
Practical Compliance Tips
• Begin with a written legal analysis. Before implementation, document how the arrangement addresses the Civil Monetary Penalties Law, the Anti-Kickback Statute, the Stark Law, MACRA, and applicable OIG guidance.
• Define savings measures prospectively. Use objective, clinically supported benchmarks and avoid open-ended standards that could be construed as rewarding reduced care.
• Decouple savings from referrals. Structure payments so they are not tied to the volume or value of referrals, admissions, procedures, or other federal healthcare program business.
• Cap and monitor physician compensation. Establish reasonable payment limits and periodically confirm that payments remain consistent with the approved methodology.
• Preserve independent clinical judgment. Make clear that physicians retain discretion to select medically necessary services, supplies, devices, and treatment approaches for each patient.
• Maintain quality safeguards. Track patient outcomes, readmissions, complications, utilization patterns, and other relevant indicators before and after implementation.
• Monitor for cherry-picking, steering, and utilization shifts. Evaluate whether participating providers avoid higher-risk patients, shift cases improperly, or alter referral patterns in ways that could raise compliance concerns.
• Maintain audit-ready documentation. Retain records of the methodology, baseline costs, savings calculations, physician participation, quality reviews, patient notices, committee approvals, exceptions, and corrective actions.
• Build in review and termination rights. Require periodic compliance review and reserve the right to suspend, amend, or terminate the arrangement if quality, utilization, or legal concerns arise.
• Train participating providers and administrators. Ensure clinical, finance, and operations personnel understand the arrangement’s limits, documentation requirements, and reporting obligations.
Conclusion
Gainsharing arrangements can remain a viable component of a provider’s value-based care and cost-efficiency strategy, but only when implemented within a disciplined legal and compliance framework. Providers should ensure that any shared-savings methodology is objective, prospectively documented, clinically justified, and supported by robust quality and patient-safety safeguards. Equally important, compensation should be structured to avoid any linkage to the volume or value of referrals or any incentive to reduce medically necessary care.
In light of the continued scrutiny of physician compensation arrangements, hospitals, health systems, and physician groups should treat gainsharing as a regulated governance initiative rather than a routine operational program. Early legal review, multidisciplinary oversight, contemporaneous documentation, periodic auditing, and clear escalation rights are essential to mitigating enforcement risk and preserving the clinical integrity of the arrangement.
